Page 23 - Enforcement Report News Today : Breaking News, Live Updates & Top Stories | Vimarsana

[co-author: Madison Gaudreau] On April 14, 2021, the U.S. Senate confirmed the nomination of Gary Gensler as the 33rd Chair of the U.S. Securities and Exchange Commission (“SEC” or “Commission”).[1] This change will bring forth a Democratic majority at the SEC which, in turn, suggests that the Commission will change its current emphasis on capital formation to focus more on investor protection and the following other areas: rules required by the Dodd-Frank Wall Street Reform and Consumer Protection Act (“Dodd-Frank Act”) such as security-based swaps, compensation, and stress tests...

7:48 am Anti-corruption enforcement is a slow-moving vehicle. Investigations into business bribery allegations can take years to resolve, even with the application of significant agency resources. Building up enough prosecutorial capacity to handle a reasonable caseload requires its own long-term effort, both institutionally and politically. The long-haul nature of enforcement is reflected in the 2020 Global Enforcement Report published by TRACE last month. Tracking the number of open transnational bribery investigations and completed enforcement actions across jurisdictions and industries...

Dr Reddy's Laboratories is recalling 2,24,710 (500 count) bottles of Atorvastatin Calcium tablets. Leading home grown drug makers Sun Pharma, Dr Reddy's Laboratories, Aurobindo Pharma and Jubilant Pharma are recalling products in the U.S. market, the world's largest market for pharmaceutical products, for various reasons. As per the latest Enforcement Report by the U.S. Food and Drug Administration (USFDA), Sun Pharma is recalling Cequa ophthalmic solution, which is used to treat chronic dry eye. The U.S.-based subsidiary of the Mumbai-based drug major is recalling 37,400 cartons (60 vial...

Leading home grown drug makers Sun Pharma, Dr Reddy's Laboratories, Aurobindo Pharma and Jubilant Pharma are recalling products in the US market, the world's largest market for pharmaceutical products, for various reasons. As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), Sun Pharma is recalling Cequa ophthalmic solution, which is used to treat chronic dry eye. The US-based subsidiary of the Mumbai-based drug major is recalling 37,400 cartons (60 vials per carton) of the ophthalmic solution for being "subpotent", the US health regulator said. The Princet...

Facebook has released its Community Standards Enforcement Report for last quarter of October to December 2020.